Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Collegium Pharmaceutical
COLL
5
Teradata Corp
TDC
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -0.98%206.63M | -26.22%561.64M | -18.42%178.92M | -100.82%-1.56M | -13.13%175.61M | 40.27%208.68M | 2.23%761.24M | 9.43%219.32M | -9.22%191M | 7.34%202.16M |
Net income from continuing operations | -23.44%43.06M | -94.10%28.13M | 3.34%89.22M | -177.01%-70.48M | -153.40%-46.85M | -73.33%56.24M | 40.32%476.46M | -0.08%86.33M | -28.83%91.52M | 19.56%87.73M |
Operating gains losses | 2.47%-5.49M | -2.88%-27.14M | -14.26%-7.88M | 53.64%-6.71M | 16.49%-6.92M | -271.83%-5.63M | 13.34%-26.38M | 22.62%-6.9M | -99.39%-14.48M | 25.51%-8.28M |
Depreciation and amortization | 4.59%97.09M | 13.68%384.97M | 3.50%99.08M | 17.12%99.32M | 14.61%93.75M | 21.62%92.83M | -1.41%338.65M | 11.13%95.73M | -5.06%84.8M | -5.14%81.8M |
Deferred tax | -160.64%-5.34M | -132.00%-45.32M | -89.36%2.47M | -189.25%-24.79M | -217.90%-31.81M | -86.17%8.81M | 40.45%141.64M | -47.35%23.19M | 7.93%27.78M | 44.18%26.98M |
Other non cash items | 25.40%4.99M | 110.65%17.19M | 60.71%4.87M | 10.70%4.34M | 4.21%4.01M | 102.31%3.98M | -736.07%-161.45M | 54.09%3.03M | 112.98%3.92M | -14.28%3.85M |
Change In working capital | 63.73%51.65M | 78.08%-20.13M | -1,250.91%-26.67M | -28.94%-34.89M | 178.17%9.89M | 162.93%31.55M | -70.23%-91.81M | 92.11%-1.97M | -172.43%-27.06M | -334.04%-12.65M |
-Change in receivables | 318.09%17.66M | 54.79%-34.52M | -55.28%3.98M | 29.55%-25.8M | 87.79%-4.6M | 26.06%-8.1M | 19.17%-76.36M | 19.81%8.9M | 11.03%-36.62M | 22.57%-37.69M |
-Change in inventory | 36.61%-232K | 83.85%-529K | 281.95%4.87M | -276.45%-2.95M | -8.16%-2.08M | -4.57%-366K | 73.46%-3.28M | -309.39%-2.68M | 138.64%1.67M | 11.42%-1.92M |
-Change in prepaid assets | 311.81%7.88M | 33.74%-12.13M | 103.10%451K | -32.67%-2.07M | -1,582.82%-12.43M | 162.77%1.91M | -12,388.59%-18.31M | -251.52%-14.54M | -134.99%-1.56M | 117.23%838K |
-Change in payables and accrued expense | 22.49%37.25M | 91.43%-1.27M | -418.02%-37.15M | -176.56%-18.84M | 87.14%24.31M | 193.03%30.41M | -257.11%-14.84M | 134.24%11.68M | -177.34%-6.81M | -63.91%12.99M |
-Change in other working capital | -242.12%-10.92M | 35.09%28.33M | 122.11%1.18M | -9.14%14.77M | -64.31%4.69M | 349.25%7.68M | -51.56%20.97M | 41.82%-5.35M | -27.03%16.26M | -21.82%13.14M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -0.98%206.63M | -26.22%561.64M | -18.42%178.92M | -100.82%-1.56M | -13.13%175.61M | 40.27%208.68M | 2.23%761.24M | 9.43%219.32M | -9.22%191M | 7.34%202.16M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 41.46%-64.96M | 51.94%-362.35M | 29.29%-93.68M | 79.96%-75.34M | 27.42%-82.36M | 15.96%-110.97M | -18.75%-754M | -48.07%-132.48M | -62.25%-376M | 31.39%-113.47M |
Net PPE purchase and sale | 4.54%-61.83M | -26.42%-233.43M | -4.37%-55.36M | -35.46%-58.56M | -28.62%-54.73M | -41.36%-64.78M | 55.43%-184.65M | 31.57%-53.04M | 65.96%-43.23M | 64.21%-42.55M |
Net business purchase and sale | 92.95%-3.06M | 78.42%-121.22M | 53.73%-36.76M | 95.83%-13.89M | 61.68%-27.18M | 44.72%-43.4M | -154.57%-561.63M | -564.37%-79.44M | -217.72%-332.77M | -52.61%-70.92M |
Net investment purchase and sale | 97.74%-63K | 0.21%-7.7M | ---1.56M | ---2.89M | ---453K | 63.81%-2.79M | ---7.72M | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 41.46%-64.96M | -3.53%-362.35M | 29.29%-93.68M | 79.96%-75.34M | 27.42%-82.36M | -140.80%-110.97M | -13.15%-350M | -58.84%-132.48M | -528.21%-376M | 31.39%-113.47M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -46.34%-139.93M | 52.23%-200.12M | -6.15%-86.89M | -55.00%82.43M | -2.95%-100.04M | 77.40%-95.62M | 2.43%-418.94M | 29.22%-81.85M | 162.53%183.18M | -334.03%-97.17M |
Net issuance payments of debt | -14.44%-92.89M | -75.73%101.8M | 6.39%61.92M | -66.97%137.24M | -111.27%-16.2M | 59.01%-81.17M | 25.84%419.38M | -51.55%58.2M | 502.62%415.49M | -37.00%143.69M |
Net common stock issuance | ---22.01M | 66.95%-270.44M | -0.05%-140.09M | 76.70%-51.79M | 67.38%-78.56M | --0 | -8.83%-818.18M | 40.70%-140.02M | -11.19%-222.28M | 0.24%-240.79M |
Cash dividends paid | ---12.88M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | ---- |
Proceeds from stock option exercised by employees | 3,134.78%2.23M | -49.20%253K | 193.33%132K | ---- | ---- | 1.47%69K | -95.57%498K | -89.16%45K | ---- | ---- |
Net other financing activities | 46.86%-7.72M | -53.81%-31.73M | -144.31%-15.78M | 65.26%-1.43M | --0 | -44.40%-14.52M | 6.55%-20.63M | 21.13%-6.46M | -154.82%-4.11M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -46.34%-139.93M | 52.23%-200.12M | -6.15%-86.89M | -55.00%82.43M | -2.95%-100.04M | 77.40%-95.62M | 2.43%-418.94M | 29.22%-81.85M | 162.53%183.18M | -334.03%-97.17M |
Net cash flow | ||||||||||
Beginning cash position | -17.86%9M | -38.35%10.96M | 90.81%11.05M | -22.66%5.92M | -17.41%13.15M | -38.35%10.96M | 39.96%17.77M | -62.51%5.79M | -34.56%7.66M | 40.61%15.92M |
Current changes in cash | -16.48%1.74M | 89.31%-823K | -133.00%-1.65M | 402.68%5.53M | 19.98%-6.79M | 187.95%2.09M | -229.23%-7.7M | 263.56%4.99M | -134.64%-1.83M | -1,615.54%-8.49M |
Effect of exchange rate changes | -163.73%-65K | -228.57%-1.13M | -320.44%-399K | -800.00%-405K | -288.65%-432K | -80.27%102K | 200.00%882K | -81.15%181K | 97.07%-45K | 230.86%229K |
End cash Position | -18.77%10.68M | -17.86%9M | -17.86%9M | 90.81%11.05M | -22.66%5.92M | -17.41%13.15M | -38.35%10.96M | -38.35%10.96M | -62.51%5.79M | -34.56%7.66M |
Free cash flow | -0.20%129.44M | -48.76%262.35M | -32.83%102.74M | -160.86%-74.28M | -26.69%104.19M | 36.67%129.71M | 98.57%512.03M | 46.60%152.96M | 86.88%122.05M | 193.63%142.12M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |